The holiday weekend didn’t seem to slow New England deals making down.
—MedicalRecords, a Cambridge, MA-based startup connecting doctors with sellers of health record software, is working on raising its first outside funding round. It’s got about 60 percent of a targeted $500,000 round committed, from investors like Ty Danco and Peter Bordes.
—New Haven, CT-based antibiotics developer Rib-X Pharmaceuticals filed federal documents that reveal its plans to go public. The company has raised $208.4 million in venture funding and recently inked a partnership with Sanofi that could be worth as much as $772 million.
—Mundipharma will provide more than $50 million in funding in 2013 to Cambridge-based Infinity Pharmaceuticals as an expansion of a drug development partnership first inked in 2008. The money will go to developing drug candidates from Infinity (NASDAQ: [[ticker:INFI]]) such as IPI-145, which is being designed to target blood cancers and inflammatory conditions.
—VMTurbo, a Waltham, MA-based virtualization management software developer, announced that it had wrapped up a $10 million Series B investment led by its return backers Bain Capital Ventures and Highland Capital Partners. The new funding will go to product development, customer support, sales, and marketing.
—Skyhook Wireless has inked a deal to get its location-finding technology into the new Norton Anti-Theft Web service, from Mountain View, CA-based Symantec (NASDAQ: [[ticker:SYMC]]). The Norton service enables people to lock, locate, and, ideally, recover a lost or stolen Windows-based laptop, and Android smartphone or tablet, with Skyhook’s technology that use GPS, WiFi and cellular signals to track a device.
—ChoiceStream, a Cambridge-based developer of software for personalizing e-commerce shopping experiences for consumers, raised $8.7 million of a targeted $12.3 million equity and options offering, an SEC filing showed.
—Boston-based Summit Partners led a $10 million investment LogiXML, a maker of Web-based business intelligence software. Other LogiXML investors include Grotech Ventures and Updata Partners.
—Civitas, a Chelsea, MA-based spinout of the biotech Alkermes (NASDAQ: [[ticker:ALKS]]), will get an undisclosed grant award from the Michael J. Fox Foundation for Parkinson’s Reseach to put towards development of an inhaled form of the Parkinson’s treatment levodopa (L-dopa).
